145 related articles for article (PubMed ID: 28621161)
1. DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review.
Emmett RA; Davidson KL; Gould NJ; Arasaradnam RP
Epigenomics; 2017 Jul; 9(7):1029-1042. PubMed ID: 28621161
[TBL] [Abstract][Full Text] [Related]
2. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
[TBL] [Abstract][Full Text] [Related]
3. A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
Garrity-Park MM; Loftus EV; Bryant SC; Smyrk TC
Inflamm Bowel Dis; 2016 Jul; 22(7):1568-74. PubMed ID: 27135485
[TBL] [Abstract][Full Text] [Related]
4. Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
Liu C; Yuan ZY; Yuan H; Wu KX; Cao B; Ren KY; Cui MJ; Liu JH; Chen HX; Pang YW
Inflamm Bowel Dis; 2021 Mar; 27(4):522-529. PubMed ID: 32793962
[TBL] [Abstract][Full Text] [Related]
5. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
6. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
[TBL] [Abstract][Full Text] [Related]
7. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
9. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
[TBL] [Abstract][Full Text] [Related]
10. The study of methylation and single nucleotide polymorphisms of cancer-related genes in patients with early-stage ulcerative colitis.
Chen HX; Yuan ZY; Wu KX; Liu C; Mao QD; He BG; Yuan H
Scand J Gastroenterol; 2019 Apr; 54(4):427-431. PubMed ID: 31046486
[No Abstract] [Full Text] [Related]
11. Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.
Wheeler JM; Kim HC; Efstathiou JA; Ilyas M; Mortensen NJ; Bodmer WF
Gut; 2001 Mar; 48(3):367-71. PubMed ID: 11171827
[TBL] [Abstract][Full Text] [Related]
12. Accelerated age-related CpG island methylation in ulcerative colitis.
Issa JP; Ahuja N; Toyota M; Bronner MP; Brentnall TA
Cancer Res; 2001 May; 61(9):3573-7. PubMed ID: 11325821
[TBL] [Abstract][Full Text] [Related]
13. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
[TBL] [Abstract][Full Text] [Related]
14. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
15. miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
Benderska N; Dittrich AL; Knaup S; Rau TT; Neufert C; Wach S; Fahlbusch FB; Rauh M; Wirtz RM; Agaimy A; Srinivasan S; Mahadevan V; Rümmele P; Rapti E; Gazouli M; Hartmann A; Schneider-Stock R
Inflamm Bowel Dis; 2015 Sep; 21(9):2039-51. PubMed ID: 26083618
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitis.
Gould NJ; Davidson KL; Nwokolo CU; Arasaradnam RP
Epigenomics; 2016 May; 8(5):667-84. PubMed ID: 27096966
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
Garrity-Park M; Loftus EV; Sandborn WJ; Smyrk TC
Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
[TBL] [Abstract][Full Text] [Related]
18. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.
Sato F; Shibata D; Harpaz N; Xu Y; Yin J; Mori Y; Wang S; Olaru A; Deacu E; Selaru FM; Kimos MC; Hytiroglou P; Young J; Leggett B; Gazdar AF; Toyooka S; Abraham JM; Meltzer SJ
Cancer Res; 2002 Dec; 62(23):6820-2. PubMed ID: 12460892
[TBL] [Abstract][Full Text] [Related]
20. Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.
Gerçeker E; Boyacıoglu SO; Kasap E; Baykan A; Yuceyar H; Yıldırım H; Ayhan S; Ellidokuz E; Korkmaz M
Oncol Rep; 2015 Oct; 34(4):1905-14. PubMed ID: 26259750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
